Anixa Biosciences Inc. – Filings and Transcripts

NASDAQ: ANIX
Share price (3/17/26): $2.89
Market cap (3/17/26): $96.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 01/31/26 Q1

ended 10/31/25 FY 2025

ended 07/31/25 Q3

ended 04/30/25 Q2

ended 01/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Baskies Arnold M

Catelani Michael

Titterton Lewis H Jr

Gottschalk Emily

News Filter

Shareholder Vote Results, Material Disclosure, Financial Statements or Exhibits

Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation

Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants

Shareholder Vote Results, Material Disclosure, Financial Statements or Exhibits

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data From Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC